Vaccinia Virus D8L (VACV D8L) (AA 1-304) anticorps
Aperçu rapide pour Vaccinia Virus D8L (VACV D8L) (AA 1-304) anticorps (ABIN7179616)
Antigène
Reactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1-304
-
Fonction
- D8L Antibody
-
Purification
- Protein G purified
-
Pureté
- >95 %
-
Immunogène
- Recombinant Vaccinia virus Cell surface-binding protein (1-304AA)
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- Vaccinia Virus D8L (VACV D8L)
-
Autre désignation
- Vaccinia virus D8L
-
Sujet
-
Background: Binds to chondroitin sulfate on the cell surface to provide virion attachment to target cell.
Aliases: D8LCell surface-binding protein antibody, Carbonic anhydrase homolog antibody
-
UniProt
- P20508
Antigène
-